Trial Profile
To evaluate the efficacy and safety of Panitumumab after progression on Cituximab in combination with Irinotecan-based chemotherapy (FOLFIRI) among patients with Metastatic Wild-type KRAS Colorectal Cancer: Data from CORECT registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary) ; Cetuximab; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 25 Oct 2016 New trial record
- 01 Sep 2016 Results assessing efficacy and safety of Panitumumab published in the Anticancer Research (2016).